HPI - Consolidated Statements of Cash Flows - USD ($) $ in Thousands		6 Months Ended
		Jun. 30, 2025	Jun. 30, 2024
Operating activities:
Net income		$ 119,221	$ 91,983
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization		146,084	147,416
Amortization of lease incentives and acquisition-related intangible assets and liabilities		1,122	565
Share-based compensation expense		6,277	5,958
Net credit losses on operating lease receivables		139	556
Accrued interest on mortgages and notes receivable		(496)	(166)
Amortization of debt issuance costs		2,821	2,788
Amortization of cash flow hedges		(124)	(124)
Amortization of mortgages and notes payable fair value adjustments		56	56
Losses on debt extinguishment		0	173
Net gains on disposition of property		(82,215)	(42,231)
Equity in earnings of unconsolidated affiliates		(1,625)	(1,774)
Distributions of earnings from unconsolidated affiliates		3,516	2,851
Changes in operating assets and liabilities:
Accounts receivable		2,841	(916)
Prepaid expenses and other assets		(4,904)	(4,838)
Accrued straight-line rents receivable		(6,004)	(5,863)
Accounts payable, accrued expenses and other liabilities		(23,854)	5,931
Net cash provided by operating activities		162,855	202,365
Investing activities:
Investments in acquired real estate and related intangible assets, net of cash acquired		(137,828)	0
Investments in development in-process		(593)	(4,149)
Investments in tenant improvements and deferred leasing costs		(61,919)	(65,880)
Investments in building improvements		(21,551)	(16,577)
Net proceeds from disposition of real estate assets		137,779	77,428
Distributions of capital from unconsolidated affiliates		3,742	5,331
Investments in mortgages and notes receivable		(1,577)	(6,229)
Repayments of mortgages and notes receivable		6,333	31
Investments in and advances to unconsolidated affiliates		(16,681)	(42,126)
Changes in earnest money deposits		10,000	0
Changes in other investing activities		139	(3,789)
Net cash used in investing activities		(82,156)	(55,960)
Financing activities:
Dividends on Common Stock		(107,738)	(105,870)
Redemptions/repurchases of Preferred Stock		(2,095)	0
Redemptions of Common Units		(10)	0
Dividends on Preferred Stock		(1,207)	(1,242)
Distributions to noncontrolling interests in the Operating Partnership		(2,151)	(2,151)
Distributions to noncontrolling interest in consolidated affiliates		(160)	(100)
Proceeds from the issuance of Common Stock		2,191	744
Costs paid for the issuance of Common Stock		(324)	0
Repurchase of shares related to tax withholdings		(2,009)	(1,429)
Borrowings on revolving credit facility		237,000	90,000
Repayments of revolving credit facility		(194,000)	(110,000)
Repayments of mortgages and notes payable		(3,865)	(3,473)
Payments for debt issuance costs and other financing activities		0	(7,648)
Net cash used in financing activities		(74,368)	(141,169)
Net increase in cash and cash equivalents and restricted cash		6,331	5,236
Cash and cash equivalents and restricted cash at beginning of the period		33,677	31,569
Cash and cash equivalents and restricted cash at end of the period		40,008	36,805
Reconciliation of cash and cash equivalents and restricted cash:
Cash and cash equivalents at end of the period		21,193	27,003
Restricted cash at end of the period		18,815	9,802
Supplemental disclosure of cash flow information:
Cash paid for interest, net of amounts capitalized		71,400	56,237
Supplemental disclosure of non-cash investing and financing activities:
Conversions of Common Units to Common Stock		0	132
Changes in accrued capital expenditures	[1]	(2,218)	(1,431)
Write-off of fully depreciated real estate assets		54,439	41,419
Write-off of fully amortized leasing costs		25,199	13,720
Write-off of fully amortized debt issuance costs		0	4,083
Adjustment of noncontrolling interests in the Operating Partnership to fair value		927	7,467
Accrued capital expenditures included in accounts payable, accrued expenses and other liabilities		$ 50,700	$ 54,100

[1] Accrued capital expenditures included in accounts payable, accrued expenses and other liabilities as of June 30, 2025 and 2024 were $50.7 million and $54.1 million, respectively.